Factors Influencing PAP and Its PM Among Patient Undergoing Elective Surgeries at Tertiary Care Hospital Mardan

January 6, 2025 updated by: Muhammad Naveed Babur, Superior University

Factors Influencing Postsurgical Acute Pain and Its Pharmacological Management Among Patient Undergoing Elective Surgeries at Tertiary Care Hospital Mardan

Postsurgical acute pain is a critical factor impacting recovery, patient satisfaction, and the risk of complications in surgical patients. Effective pain management is essential for enhancing patient outcomes and reducing the likelihood of chronic pain development.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

However, pain perception is influenced by various factors, including demographic characteristics, types, duration and complexity of surgery, and pharmacological approaches. This study aims to identify these contributing factors and assess the effectiveness of different analgesics in managing postsurgical pain in a tertiary care setting.

Study Type

Observational

Enrollment (Actual)

386

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Khyber Pakhtunkhwa
      • Mardan, Khyber Pakhtunkhwa, Pakistan
        • Mardan Medical Complex

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

To determine factors influencing Postsurgical acute pain

Description

Inclusion Criteria:

  • Patients with ages of 18 years and above.
  • ASA Class I,II are scheduled for elective surgeries under general anesthesia at Tertiary care hospital Mardan.

Exclusion Criteria:

  • Chronic opioid and NSAID user, tricyclic antidepressants and selective serotonin reuptake inhibitors.
  • People with bleeding disorders.
  • Postoperative respiratory depression, patient with emergency surgeries or admitted to ICU Postoperative.
  • Procedure perform under regional Anesthesia, history of hypersensitivity to analgesic drugs and refusal to participate"

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analog scale
Time Frame: 12 Months
Visual analog scale (0-10 VAS)and it was categorized using the following terms : no pain (0), mild (1-3), moderate (4-6),severe (7-9),or worse pain (10)
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2024

Primary Completion (Actual)

July 1, 2024

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

December 18, 2024

First Submitted That Met QC Criteria

January 6, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 6, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • MSAHS/Batch-Spring23/025

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery-Complications

Clinical Trials on Gruop 1

Subscribe